Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: A study protocol for a randomized controlled clinical trial

BMC Endocrine Disorders

Volumn 11, Issue , 2011, Pages

  Shab Bidar, Sakineh ^a   Neyestani, Tirang R ^b   Djazayery, Abolghassem ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Polymorphism; Study protocol; Type 2 diabetes; Vitamin D; Vitamin D receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CALCIFEDIOL; CALCIUM; COLECALCIFEROL; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN APA1; PROTEIN BSM1; PROTEIN FOKI; PROTEIN TAQ1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; YOGHURT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE; BLOOD SAMPLING; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; FOOD FREQUENCY QUESTIONNAIRE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMATOCRIT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUN EXPOSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 79959331910     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-11-12     Document Type: Article

References (56)

1. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998, 21(2):296-309. American Diabetes Association.
2. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. Jama 2003, 290(14):1884-1890. 10.1001/jama.290.14.1884, 14532317.
3. Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992, 8(4):287-338. 10.1002/dmr.5610080402, 1307522.
4. Jin W, Patti ME. Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes. Clin Sci (Lond) 2009, 116(2):99-111.
5. Gillies PJ. Nutrigenomics: the Rubicon of molecular nutrition. J Am Diet Assoc 2003, 103(12 Suppl 2):S50-55.
6. Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000, 58(4):250-264.
7. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ. Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 2003, 1(1):E20. 10.1371/journal.pbio.0000020, 212698, 14551916.
8. Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am 2010, 39(2):401-418. table of contents, 10.1016/j.ecl.2010.02.011, 20511060.
9. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010, 88(5):441-450. 10.1007/s00109-010-0590-9, 2861286, 20119827.
10. Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab 2005, 31(4 Pt 1):318-325.
11. Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev 2006, 64(11):479-486. 10.1111/j.1753-4887.2006.tb00180.x, 17131943.
12. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008, 10(3):185-197. 10.1111/j.1463-1326.2007.00710.x, 18269634.
13. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 2005, 16(6):261-266. 10.1016/j.tem.2005.06.004, 15996876.
14. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51(5):1367-1374. 10.2337/diabetes.51.5.1367, 11978632.
15. Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 1984, 73(3):759-766. 10.1172/JCI111269, 425078, 6323527.
16. Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986, 29(3):142-145. 10.1007/BF02427083, 3516771.
17. Avenell A, Cook JA, MacLennan GS, McPherson GC. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009, 38(5):606-609. 10.1093/ageing/afp109, 19617604.
18. Schwalfenberg G. Vitamin D and diabetes: improvement of glycemic control with vitamin D3 repletion. Can Fam Physician 2008, 54(6):864-866. 2426990, 18556494.
19. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83(4):754-759.
20. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30(4):980-986. 10.2337/dc06-1994, 17277040.
21. Neyestani T, Gharavi A, Kalayi A. Iranian diabetics may not be Vitamin D deficient more than healthy subjects. Acta Medica Iranica 2008, 46(4).
22. Campbell IT, Jarrett RJ, Keen H. Diurnal and seasonal variation in oral glucose tolerance: studies in the Antarctic. Diabetologia 1975, 11(2):139-145. 10.1007/BF00429838, 168108.
23. Gikas A, Sotiropoulos A, Pastromas V, Papazafiropoulou A, Apostolou O, Pappas S. Seasonal variation in fasting glucose and HbA1c in patients with type 2 diabetes. Prim Care Diabetes 2009, 3(2):111-114. 10.1016/j.pcd.2009.05.004, 19535310.
24. Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract 2010, 16(4):600-608. 10.4158/EP09300.OR, 20350923.
25. Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2010, 2(1):36-40. 10.1111/j.1753-0407.2009.00057.x, 20923473.
26. Bid HK, Konwar R, Aggarwal CG, Gautam S, Saxena M, Nayak VL, Banerjee M. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci 2009, 63(5):187-194. 10.4103/0019-5359.53164, 19584489.
27. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995, 38(10):1239-1245. 10.1007/BF00422375, 8690178.
28. Taylor AV, Wise PH. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 1998, 74(872):365-366. 10.1136/pgmj.74.872.365, 2360945, 9799895.
29. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001, 24(8):1496.. 10.2337/diacare.24.8.1496, 11473093.
30. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57(4):258-261.
31. Allegra V, Luisetto G, Mengozzi G, Martimbianco L, Vasile A. Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3. Nephron 1994, 68(1):41-47. 10.1159/000188085, 7991039.
32. Sadighi J, Sheikholeslam R, Mohammad K, Pouraram H, Abdollahi Z, Samadpour K, Kolahdooz F, Naghavi M. Flour fortification with iron: a mid-term evaluation. Public Health 2008, 122(3):313-321. 10.1016/j.puhe.2007.05.002, 17645902.
33. Nichols GA, Moler EJ. Metabolic Syndrome Components Are Associated with Future Medical Costs Independent of Cardiovascular Hospitalization and Incident Diabetes. Metab Syndr Relat Disord 2010,
34. Halpern A, Mancini MC, Magalhaes ME, Fisberg M, Radominski R, Bertolami MC, Bertolami A, de Melo ME, Zanella MT, Queiroz MS, et al. Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr 2010, 2:55. 10.1186/1758-5996-2-55, 2939537, 20718958.
35. Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 2003, 77(6):1478-1483.
36. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl 1):S61-78.
37. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath JJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007, 85(3):649-650.
38. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005, 135(2):317-322.
39. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85(7):2402-2410. 10.1210/jc.85.7.2402, 10902785.
40. Neyestani TR, Gharavi A, Kalayi A. Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res 2007, 77(5):341-346. 10.1024/0300-9831.77.5.341, 18453319.
41. Neyestani TR, Fereydouni Z, Hejazi S, Salehi-Nasab F, Nateghifard F, Maddah M, Karandish M. Vitamin C status in Iranian children with acute lymphoblastic leukemia: evidence for increased utilization. J Pediatr Gastroenterol Nutr 2007, 45(1):141-144. 10.1097/MPG.0b013e31804c5047, 17592383.
42. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978, 90(1):37-43. 10.1016/0009-8981(78)90081-5, 719890.
43. Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J Endocrinol Invest 2007, 30(10):833-838.
44. Neyestani TR, Gharavi A, Kalayi A. Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions. Int J Food Sci Nutr 2009, 60(Suppl 1):79-88.
45. Deng HW, Shen H, Xu FH, Deng HY, Conway T, Zhang HT, Recker RR. Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 2002, 17(4):678-686. 10.1359/jbmr.2002.17.4.678, 11918225.
46. Ye WZ, Reis AF, Velho G. Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene. J Hum Genet 2000, 45(1):56-57. 10.1007/s100380050011, 10697965.
47. Liu PY, Zhang YY, Lu Y, Long JR, Shen H, Zhao LJ, Xu FH, Xiao P, Xiong DH, Liu YJ, et al. A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases. J Med Genet 2005, 42(3):221-227. 10.1136/jmg.2004.024752, 1736011, 15744035.
48. Purcell S, Daly MJ, Sham PC. WHAP: haplotype-based association analysis. Bioinformatics 2007, 23(2):255-256. 10.1093/bioinformatics/btl580, 17118959.
49. Bonjour JP, Benoit V, Pourchaire O, Ferry M, Rousseau B, Souberbielle JC. Inhibition of markers of bone resorption by consumption of vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women. Br J Nutr 2009, 102(7):962-966. 10.1017/S0007114509371743, 19519975.
50. Johnson JL, Mistry VV, Vukovich MD, Hogie-Lorenzen T, Hollis BW, Specker BL. Bioavailability of vitamin D from fortified process cheese and effects on vitamin D status in the elderly. J Dairy Sci 2005, 88(7):2295-2301. 10.3168/jds.S0022-0302(05)72907-6, 15956292.
51. Arabi A, Zahed L, Mahfoud Z, El-Onsi L, Nabulsi M, Maalouf J, Fuleihan Gel H. Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls. Bone 2009, 45(6):1091-1097. 10.1016/j.bone.2009.07.074, 19647104.
52. Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem 2009, 42(10-11):1174-1177. 10.1016/j.clinbiochem.2009.03.008, 19302999.
53. Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009, 29(9):3713-3720.
54. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, Soltani A, Shafaei AR, Hamidi Z, Fard AR, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004, 4:38. 10.1186/1471-2458-4-38, 517720, 15327695.
55. Clements MR, Davies M, Hayes ME, Hickey CD, Lumb GA, Mawer EB, Adams PH. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol (Oxf) 1992, 37(1):17-27.
56. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69(5):842-856.